학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 121건 | 목록 1~20
Academic Journal
Verdura S; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.; Cuyàs E; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.; Lozano-Sánchez J; Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.; Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain.; Bastidas-Velez C; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.; Llorach-Parés L; Mind the Byte, Barcelona, Spain.; Fernández-Arroyo S; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain.; Hernández-Aguilera A; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain.; Joven J; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain.; Nonell-Canals A; Mind the Byte, Barcelona, Spain.; Bosch-Barrera J; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.; Department of Medical Sciences, Medical School, University of Girona, Girona, Spain.; Medical Oncology, Girona, Spain.; Martin-Castillo B; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain.; Vellon L; Stem Cells Laboratory, Institute of Biology and Experimental Medicine (IBYME-CONICET), Buenos Aires, Argentina.; Sanchez-Martinez M; Mind the Byte, Barcelona, Spain.; Segura-Carretero A; Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.; Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain.; Menendez JA; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain.
Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE
Academic Journal
Corominas-Faja B; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Cuyàs E; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Lozano-Sánchez J; Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.; Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain.; Cufí S; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Verdura S; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Fernández-Arroyo S; Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain.; The Campus of International Excellence Southern Catalonia, Tarragona, Spain.; Borrás-Linares I; Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain.; Martin-Castillo B; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain.; Martin ÁG; StemTek Therapeutics, Bilbao, Spain.; Lupu R; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Cancer Center, Rochester MN, USA.; Nonell-Canals A; Mind the Byte, Barcelona, Spain.; Sanchez-Martinez M; Mind the Byte, Barcelona, Spain.; Micol V; Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain.; CIBER, Fisiopatología de la Obesidad y la Nutrición, CIBERobn, Instituto de Salud Carlos III (CB12/03/30038), Madrid, Spain.; Joven J; Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain.; The Campus of International Excellence Southern Catalonia, Tarragona, Spain.; Segura-Carretero A; Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.; Research and Development Functional Food Centre (CIDAF), PTS Granada, Granada, Spain.; Menendez JA; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Metabostem, Barcelona, Spain.
Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE
Academic Journal
Cuyàs E; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Verdura S; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Llorach-Parés L; Mind the Byte, Barcelona, Spain.; Fernández-Arroyo S; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Rovira i Virgili University, Reus, Spain.; Joven J; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Rovira i Virgili University, Reus, Spain.; Martin-Castillo B; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Unit of Clinical Research, Catalan Institute of Oncology (ICO) , Girona, Spain.; Bosch-Barrera J; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Department of Medical Sciences, Medical School University of Girona, Girona, Spain.; Medical Oncology, Catalan Institute of Oncology (ICO) Dr. Josep Trueta University Hospital, Girona, Spain.; Brunet J; Medical Oncology, Catalan Institute of Oncology (ICO) Dr. Josep Trueta University Hospital, Girona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL) L'Hospitalet del Llobregat, Barcelona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO) Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Nonell-Canals A; Mind the Byte, Barcelona, Spain.; Sanchez-Martinez M; Mind the Byte, Barcelona, Spain.; Menendez JA; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: PubMed not MEDLINE
Academic Journal
JOURNAL OF CHEMICAL INFORMATION AND MODELING
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Recercat. Dipósit de la Recerca de Catalunya
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Academic Journal
Repisalud
Instituto de Salud Carlos III (ISCIII)
© Food and Chemical Toxicology, 2018, vol. 116, part B, p. 161-172
Articles publicats (IdIBGi)
Verdura, Sara Cuyàs, Elisabet Llorach Parés, Laura Pérez Sánchez, Almudena Micol, Vicente Nonell-Canals, Alfons Joven, Jorge Valiente Malmagro, Manuel Sanchez Martinez, Melchor Bosch Barrera, Joaquim Menéndez Menéndez, Javier Abel 2018 Silibinin is a direct inhibitor of STAT3 Food and Chemical Toxicology 116 Part B 161 172
DUGiDocs – Universitat de Girona
instname
Academic Journal
Proceedings of the 2nd International Conference on Complexity, Future Information Systems and Risk. :144-151
Academic Journal
Llorach-Pares L; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology and Biodiversity Research Institute (IRBio), Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. laura@mindthebyte.com.; Mind the Byte S.L., 08007 Barcelona, Catalonia, Spain. laura@mindthebyte.com.; Nonell-Canals A; Mind the Byte S.L., 08007 Barcelona, Catalonia, Spain. alfons@mindthebyte.com.; Avila C; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology and Biodiversity Research Institute (IRBio), Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. conxita.avila@ub.edu.; Sanchez-Martinez M; Mind the Byte S.L., 08007 Barcelona, Catalonia, Spain. melchor@mindthebyte.com.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101213729 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-3397 (Electronic) Linking ISSN: 16603397 NLM ISO Abbreviation: Mar Drugs Subsets: MEDLINE
Academic Journal
Aging Cell
Aging Cell, 2018, vol. 17, núm. 4, p. e12772
Articles publicats (IdIBGi)
Cuyàs, Elisabet Verdura, Sara Llorach Parés, Laura Fernández-Arroyo S Luciano-Mateo, Fedra Cabré, Noemí Stursa, Jan Werner, Lukas Martin-Castillo, Begoña Viollet, Benoit Neuzil, Jiri Joven, Jorge Nonell-Canals, Alfons Sanchez Martinez, Melchor Menéndez Menéndez, Javier Abel 2018 Metformin directly targets the H3K27me3 demethylase KDM6A/UTX Aging Cell 17 4 e12772
DUGiDocs – Universitat de Girona
instname
검색 결과 제한하기
제한된 항목
[검색어] Nonell-Canals, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어